Understanding barriers to diabetes care in the U.S.
Barriers to Equitable Guideline-Recommended Diabetes Care in the United States
This study is looking into why some people, especially those from lower-income backgrounds and different racial or ethnic groups, aren't getting the diabetes care they need, so we can find better ways to help everyone manage their diabetes effectively.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-11049550 on NIH RePORTER |
What this research studies
This research investigates the reasons why patients, particularly those from low socioeconomic backgrounds and minoritized racial/ethnic groups, do not receive recommended diabetes care. It aims to identify gaps in adherence to modern diabetes treatment guidelines and the barriers that prevent equitable access to care. By analyzing large datasets and conducting surveys with physicians, the study seeks to uncover the factors that contribute to disparities in diabetes management and treatment. The findings could help inform strategies to improve care delivery and outcomes for affected populations.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with diabetes, particularly those from low socioeconomic backgrounds or minoritized racial/ethnic groups.
Not a fit: Patients who do not have diabetes or those who are already receiving optimal diabetes care may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved access to guideline-recommended diabetes treatments for underserved populations.
How similar studies have performed: Previous research has highlighted disparities in healthcare access and treatment adherence, suggesting that addressing these barriers could lead to significant improvements in patient outcomes.
Where this research is happening
Baltimore, United States
- Johns Hopkins University — Baltimore, United States (Active)
Researchers
- Principal investigator: Shin, Jung-Im — Johns Hopkins University
- Study coordinator: Shin, Jung-Im
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.